High | P11802 | Cyclin-dependent kinase 4 OS=Homo sapiens OX=9606 GN=CDK4 PE=1 SV=2 | 0 | 4.009 | 8 | 2 | 4 | 1 | 303 | 33.7 | 7.01 | 1 | 1 | 1 | | 2 | 1 | 1 | | 356873.1563 | 270228.4375 | 282188.3438 | 438545.125 | 1 | 1 | 1 | 1 | | cell division;cell organization and biogenesis;development;metabolic process;regulation of biological process;response to stimulus | chromosome;cytoplasm;cytosol;membrane;nucleus | catalytic activity;enzyme regulator activity;nucleotide binding;protein binding | "Pf00069, Pf01636, Pf07714" | 1019 | ENSG00000135446.16 | CDK4 | 12 | Transcriptional regulation of white adipocyte differentiation; RMTs methylate histone arginines; Ubiquitin-dependent degradation of Cyclin D1; Cyclin D associated events in G1; SCF(Skp2)-mediated degradation of p27/p21; Meiotic recombination; PTK6 Regulates Cell Cycle; Oncogene Induced Senescence; Senescence-Associated Secretory Phenotype (SASP); Transcriptional regulation by RUNX2; Oxidative Stress Induced Senescence | Viral carcinogenesis; T cell receptor signaling pathway; Tight junction; Hepatitis B; Pancreatic cancer; Chronic myeloid leukemia; Non-small cell lung cancer; Breast cancer; Pathways in cancer; Glioma; AGE-RAGE signaling pathway in diabetic complications; Melanoma; HTLV-I infection; p53 signaling pathway; Measles; Small cell lung cancer; Bladder cancer; Cell cycle; Endocrine resistance; PI3K-Akt signaling pathway | 0 |